Our results showed that PIP5Kα is necessary for breast cancer cell proliferation, as evidenced by the increases in the cell proliferation markers E2F1, CDK1 and CCND1 and the decrease in the tumour suppressor FOXO3. Here, E2F1 is linked to breast carcinoma.